Epithelial-specific and stage-specific functions of insulin-like growth factor-I during postnatal mammary development.

Postnatal development of the mammary gland requires interactions between the epithelial and stromal compartments, which regulate actions of hormones and growth factors. IGF-I is expressed in both epithelial and stromal compartments during postnatal development of the mammary gland. However, little is known about how local expression of IGF-I in epithelium or stroma regulates mammary growth and differentiation during puberty and pregnancy-induced alveolar development. The goal of this study was to investigate the mechanisms of IGF-I actions in the postnatal mammary gland and test the hypothesis that IGF-I expressed in stromal and epithelial compartments has distinct functions. We established mouse lines with inactivation of the igf1 gene in mammary epithelium by crossing igf1/loxP mice with mouse lines expressing Cre recombinase under the control of either the mouse mammary tumor virus long-terminal repeat or the whey acidic protein gene promoter. Epithelial-specific loss of IGF-I during pubertal growth resulted in deficits in ductal branching. In contrast, heterozygous reduction of IGF-I throughout the gland decreased expression of cyclins A2 and B1 during pubertal growth and resulted in alterations in proliferation of the alveolar epithelium and milk protein levels during pregnancy-induced differentiation. Reduction in epithelial IGF-I at either of these stages had no effect on these indices. Taken together, our results support distinct roles for IGF-I expressed in epithelial and stromal compartments in mediating growth of the postnatal mammary gland.

[1]  W. Ruan,et al.  Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. , 2005, Endocrinology.

[2]  D. Leroith,et al.  Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes. , 2004, Diabetes.

[3]  R. Rhoads,et al.  Insulin and prolactin synergistically stimulate beta-casein messenger ribonucleic acid translation by cytoplasmic polyadenylation. , 2004, Molecular endocrinology.

[4]  T. Wood,et al.  Expression of the insulin-like growth factor binding proteins during postnatal development of the murine mammary gland. , 2004, Endocrinology.

[5]  M. P. Walker,et al.  Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specific deletion of IGF-I. , 2004, Endocrinology.

[6]  L. Hennighausen,et al.  Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice , 2001, Transgenic Research.

[7]  D. Leroith,et al.  Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse. , 2004, Novartis Foundation symposium.

[8]  R. Hovey,et al.  Morphogenesis of mammary gland development. , 2004, Advances in experimental medicine and biology.

[9]  T. Wood,et al.  The Insulin-Like Growth Factors (IGFs) and IGF Binding Proteins in Postnatal Development of Murine Mammary Glands , 2004, Journal of Mammary Gland Biology and Neoplasia.

[10]  A. Rowzee,et al.  Growth Factor Regulation of Cell Cycle Progression in Mammary Epithelial Cells , 2004, Journal of Mammary Gland Biology and Neoplasia.

[11]  Mina J Bissell,et al.  Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes , 2003, Breast Cancer Research.

[12]  J. Pollard,et al.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development , 2002, Breast Cancer Research.

[13]  T. Wood,et al.  Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells. , 2002, Endocrinology.

[14]  R. Farrar,et al.  Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. , 2002, The Journal of clinical investigation.

[15]  D. Hadsell,et al.  Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. , 2001, Endocrinology.

[16]  G. Silberstein.  Postnatal mammary gland morphogenesis , 2001, Microscopy research and technique.

[17]  D. Leroith,et al.  Conditional Knockout of Mouse Insulin-Like Growth Factor-1 Gene Using the Cre/loxP System , 2000 .

[18]  W. Ruan,et al.  Insulin-Like Growth Factor I Is Essential for Terminal End Bud Formation and Ductal Morphogenesis during Mammary Development1. , 1999, Endocrinology.

[19]  D. Leroith,et al.  Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone , 1999 .

[20]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Sjögren,et al.  Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Wood,et al.  Expression and Regulation of Insulin-like Growth Factors and Their Binding Proteins in the Normal Breast , 1999 .

[23]  T. Wood,et al.  The Insulin-Like Growth Factors (IGF) and IGF Type I Receptor during Postnatal Growth of the Murine Mammary Gland: Sites of Messenger Ribonucleic Acid Expression and Potential Functions* * This work was supported, in part, by NIH Grant DK-48103 (to T.L.W.). , 1999, Endocrinology.

[24]  D. Leroith,et al.  Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. , 1998, Molecular endocrinology.

[25]  P. Walden,et al.  Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. , 1998, Endocrinology.

[26]  L. Hennighausen,et al.  Cre-mediated gene deletion in the mammary gland. , 1997, Nucleic acids research.

[27]  J. Ross,et al.  Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. , 1996, The Journal of clinical investigation.

[28]  L. Hennighausen,et al.  Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. , 1995, Development.

[29]  W. Ruan,et al.  Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[30]  K. Flanders,et al.  Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-beta 1. , 1992, Developmental biology.

[31]  W. Ruan,et al.  Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-I messenger ribonucleic acid of rat mammary gland. , 1990, Endocrinology.

[32]  C. Osborne,et al.  Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. , 1989, Cancer research.

[33]  C. Osborne,et al.  Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. , 1989, The Journal of clinical investigation.

[34]  Kenneth P. Karey,et al.  Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. , 1988, Cancer research.

[35]  S. Deeks,et al.  Maintenance of normal rat mammary epithelial cells by insulin and insulin-like growth factor 1. , 1988, Experimental cell research.

[36]  H. Vorherr.  Endocrinology of breast cancer. , 1987, Maturitas.

[37]  L. Larson,et al.  Somatomedin-C substitutes for insulin for the growth of mammary epithelial cells from normal virgin mice in serum-free collagen gel cell culture. , 1986, Endocrinology.